Navigation Links
CV Therapeutics Reports 2008 Second Quarter Financial Results
Date:7/31/2008

or the prior quarter of $28.0 million. The decrease in cash utilization in the quarter ended June 30, 2008 compared to the prior quarter was due primarily to the timing of certain compensation and payroll related tax payments paid out in the prior quarter and higher cash receipts in the current quarter associated with higher quarter-over-quarter revenue.

Company management will webcast a conference call on July 31, 2008 at 5:00 p.m. EDT, 2:00 p.m. PDT, on the Company's website. To access the live webcast, please log on to the Company's website at http://www.cvt.com and go to the Investor Information section. Alternatively, domestic callers may participate in the conference call by dialing (866) 524-6241, and international callers may participate in the conference call by dialing (706) 679-3061. Webcast and telephone replays of the conference call will be available approximately two hours after the completion of the call through Thursday, August 7, 2008. Domestic callers can access the replay by dialing (800) 642-1687, and international callers can access the replay by dialing (706) 645-9291; the PIN access number is 56235490.

About CV Therapeutics

CV Therapeutics, Inc., headquartered in Palo Alto, California, is a biopharmaceutical company primarily focused on applying molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases. CV Therapeutics Ltd. is the company's European subsidiary based in the United Kingdom.

CV Therapeutics' approved products in the United States include Ranexa(R) (ranolazine extended-release tablets), indicated for the treatment of chronic angina in patients who have not achieved an adequate response with other antianginal drugs, and Lexiscan(TM) (regadenoson) injection for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging in patients unable to underg
'/>"/>

SOURCE CV Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
3. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
4. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
5. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
6. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
7. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
8. Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination
9. Amsterdam Molecular Therapeutics Reports Half Year Results 2007
10. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
11. Anesiva Grants Specific-Use License of Its Needle-Free Drug Delivery Technology to Particle Therapeutics for Diabetes Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... , July 28, 2015  PDL BioPharma, Inc. ... announced that the Company will release its second quarter ... 2015, on Wednesday, August 5, 2015, after market close. ... that day at 4:30 p.m. Eastern Time to discuss ... call will be available via the webcast link on ...
(Date:7/28/2015)... -- Research and Markets ( ... "Analysis of the Global Flow Cytometry Market ... Globally, flow cytometry remains a popular tool for ... stem cells. But the market is witnessing active ... from underdeveloped nations to quantitate CD4 cell markers ...
(Date:7/28/2015)... NEW YORK , July 28, 2015 ... "Company"), a diversified life sciences company, today announced that ... authorized shares of common stock of the Company from ... held on July 27, 2015 at the Law Offices ... Meeting").   At the Special Meeting, there were 480,655,929 shares ...
(Date:7/28/2015)... 28, 2015 CSL Behring announced ... accepted for review the company,s Biologics License Application (BLA) ... for the treatment of hemophilia A. In the pivotal ... Hemophilia A is a congenital bleeding ... all affected patients are male. People with hemophilia A ...
Breaking Biology Technology:PDL BioPharma to Announce Second Quarter 2015 Financial Results on August 5, 2015 2Analysis of the Global Flow Cytometry Market 2012-2018 with a 2014 Base Year and a 2015-2018 Forecast Period 2Tauriga Sciences, Inc. Stockholders Approve Increase In Authorized Common Stock 2Tauriga Sciences, Inc. Stockholders Approve Increase In Authorized Common Stock 3U.S. FDA Accepts for Review CSL Behring's Biologics License Application for Its Novel rVIII-SingleChain Therapy for Patients with Hemophilia A 2U.S. FDA Accepts for Review CSL Behring's Biologics License Application for Its Novel rVIII-SingleChain Therapy for Patients with Hemophilia A 3
... JERUSALEM and NEEDHAM, Massachusetts, December 10 /PRNewswire-FirstCall/,-- ... today announced that,three substantial medical research project ... (American Association for Respiratory Care) Congress in,Anaheim, ... of End-tidal,CO2 (EtCO2) monitoring using Oridion Microstream(R) ...
... researchers to quickly and effectively use this invaluable resource. , ... ... today announced the availability of a new tutorial suite on ... resource for the analysis of prokaryotes, including the complete sequences of ...
... Sumerlin has earned a National Science Foundation Faculty ... members who exemplify the role of teacher-scholars in ... in the Dedman College Department of Chemisty, will ... nanotechnology research projects one with potential biomedical ...
Cached Biology Technology:Oridion Announces Significant Medical Research to be Presented at AARC Congress 2Oridion Announces Significant Medical Research to be Presented at AARC Congress 3New Online Tutorial for the Comprehensive Microbial Resource (CMR) 2SMU chemist wins NSF early career award 2
(Date:7/9/2015)... 2015 Research and ... the "Biometrics for Banking; Market & Technology ... to their offering. The adoption for ... growth and the forecast is that by 2020 ... companies involved in delivering biometric systems to the ...
(Date:7/9/2015)... Calif. , July 9, 2015 /PRNewswire/ ... leading developer of human interface solutions, today ... the industry,s first fully hardware encapsulated fingerprint ... secure authentication technology is literally off the ... and biometric matching within the fingerprint sensor ...
(Date:7/8/2015)... NEW YORK , July 8, 2015 /PRNewswire/ ... today announced BD & Guidepoint Mentor, a ... access to Guidepoint,s expert network services. ... cutting-edge technologies to improve healthcare delivery and outcomes and, ... each start-up entrepreneur will be able to directly engage ...
Breaking Biology News(10 mins):Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 2Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 3BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 3
... Current arthritis medications can ease the pain, but ... aggressive treatments: use of very limited available drugs ... to find new therapeutic targets for arthritis by ... interrupted, may prevent arthritis pain caused by joint ...
... More than 300 people and 30 companies are expected ... career fair on March 13, 2009 at NJIT. The ... 3:30 p.m. in NJIT,s Campus Center, unites industry professionals ... "Explore the Leading Edge of the ...
... by the Wildlife Conservation Society, have helped the government ... protect more than 600 gorillas, along with other threatened ... Called Deng Deng National Park, the new ... kilometers) in sizeapproximately the size of the City of ...
Cached Biology News:Inhibiting proteins may prevent cartilage breakdown in arthritis patients 2NJIT to host major biomedical engineering showcase and career fair 2Wildlife Conservation Society helps Cameroon create new national park 2Wildlife Conservation Society helps Cameroon create new national park 3
... A self-contained work area that will help ... UV bulbs irradiate the work area prior ... DNA will be amplified. Containment features reduce ... hood has acrylic windows for a clear ...
...
The large Dodeca stainer shaking rack holds the staining trays in the large Dodeca stainer....
... glass slide in this set of ... in triplicate, for a total of ... proteins as internal control. Antibodies belonging ... angiogenesis, apoptosis, cell cycle progression, signal ...
Biology Products: